drugset / Trial / NCT03030066
Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas
NaSingle-groupOpen-labelTreatment
Summary
This is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132 mutations.
Timeline
- Start
- 2017-01-19
- Primary completion
- 2021-01-31
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DS-1001b | Unknown | — | Oral |